Amgen
AMGN
#101
Rank
NZ$258.55 B
Marketcap
$481.00
Share price
-4.89%
Change (1 day)
6.96%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Amgen (AMGN) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$103.21 Billion

According to Amgen's latest financial reports the company's total debt is NZ$103.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Amgen - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$102.17 B66.56%
2022-12-31NZ$61.34 B25.79%
2021-12-31NZ$48.76 B6.67%
2020-12-31NZ$45.71 B2.96%
2019-12-31NZ$44.40 B-12.22%
2018-12-31NZ$50.58 B1.65%
2017-12-31NZ$49.76 B-0.36%
2016-12-31NZ$49.94 B8.76%
2015-12-31NZ$45.92 B17.14%
2014-12-31NZ$39.20 B0.27%
2013-12-31NZ$39.09 B21.23%
2012-12-31NZ$32.24 B17.46%
2011-12-31NZ$27.45 B58.52%
2010-12-31NZ$17.31 B18.67%
2009-12-31NZ$14.59 B-16.77%
2008-12-31NZ$17.53 B20.17%
2007-12-31NZ$14.59 B14.07%
2006-12-31NZ$12.79 B120.96%
2005-12-31NZ$5.78 B-19.16%
2004-12-31NZ$7.16 B51.14%
2003-12-31NZ$4.73 B-21.8%
2002-12-31NZ$6.05 B679.19%
2001-12-31NZ$0.77 B6.79%
2000-12-31NZ$0.72 B18%
1999-12-31NZ$0.61 B-1.06%
1998-12-31NZ$0.62 B39.75%
1997-12-31NZ$0.44 B77.95%
1996-12-31NZ$0.25 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$113.84 B 10.30%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$87.83 B-14.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.72 B-64.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$39.90 B-61.34%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.36 B-88.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$121.46 B 17.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$61.09 B-40.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.56 B-95.57%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$53.18 B-48.48%๐Ÿ‡บ๐Ÿ‡ธ USA